Lawrence Goldfarb frequently writes and contributes to a variety of publications in the finance industry, including but not limited to:

"Biotechnology Venture Capital Investments" (Aspatore Books), Chapter 6, ‘A Deal is Just a Deal’

"PIPEs: A Guide to Private Investments in Public Equity," Edition 1, Chapter 8 (Bloomberg)

"Biotechs fear SEC's closer scrutiny of PIPE deal" (San Francisco Business Times)

"Redefining Fees and Performance" (Alpha, by Institutional Investor)

"Reality Check Time for Hedge Fund" (eFinancialNews)